More on GALT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.0 Score)
- Holders

Upcoming Events

- Earnings (8/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Galectin Therapeutics (NQ:GALT)
Delayed: 2.83 +0.06 (2.17%)
Prev. Close $2.77  
Open$2.79 
52 Wk High$3.05 
52 Wk Low$0.49 
Day High$2.93 
Day Low$2.77 
P/E N/A  
EPS$-1.32 
Volume336,750 


May 28, 2026 09:13 AM Form 4 GALECTIN THERAPEUTICS For: May 26 Filed by: Jamil Khurram
May 27, 2026 08:00 AM Galectin Therapeutics Presents New EASL 2026 Oral and Poster Analyses Demonstrating Belapectin’s Potential to Modify Disease Progression in Advanced MASH Cirrhosis
May 15, 2026 08:00 AM Galectin Therapeutics Reports March 31, 2026 Financial Results and Provides Business Update
May 15, 2026 07:51 AM Form 8-K GALECTIN THERAPEUTICS For: May 15
May 15, 2026 07:46 AM Form 10-Q GALECTIN THERAPEUTICS For: Mar 31
May 11, 2026 08:00 AM Galectin Therapeutics publishes belapectin trial results in Hepatology
May 11, 2026 08:00 AM Galectin Therapeutics Announces Publication of NAVIGATE Phase 2b Trial Results for Belapectin in the Journal of Hepatology
Apr 13, 2026 06:04 AM Form EFFECT GALECTIN THERAPEUTICS
Mar 31, 2026 04:15 PM Galectin Therapeutics (GALT) files mixed shelf
Mar 31, 2026 04:12 PM Form S-3 GALECTIN THERAPEUTICS
View All Articles

Entities mentioned with GALT

View All Entities